Status:
RECRUITING
Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic
Lead Sponsor:
Nantes University Hospital
Conditions:
Patients Undergoing Cardiac or Thoracic Surgery
Eligibility:
All Genders
18+ years
Brief Summary
This study will describe the recovery process of patients undergoing cardiac surgery during the covid-19 pandemic. This will focus on hemodynamic failure and organ dysfunction after surgery. Capturin...
Detailed Description
Performing cardiac surgery in the context of SARS-CoV2 infection is potentially at risk of marked post-operative hemodynamic failure (shock) due to the inflammatory reaction generated by the surgery a...
Eligibility Criteria
Inclusion
- Adults (age ≥18 years) undergoing cardiac or thoracic surgery
- With positive PCR in the 5 days before or after cardiac/thoracic surgery.
Exclusion
- Minors
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04389463
Start Date
May 11 2020
End Date
June 30 2026
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Nantes, France, 44093